DV
Dividend Vision

CLPT — Clearpoint Neuro Inc

Clearpoint Neuro Inc (CLPT)

Total return is 1945.3% over the past 14.2 years, 1291.4 points ahead of SPY at 653.9%. Its deepest 1-year drawdown was 70.7%.

CLPT is an equity stock focused on Clearpoint Neuro Inc, a medical device company operating in the neurotech sector. The fund does not currently pay distributions, making it unsuitable for income-focused investors seeking regular dividend payments. This holding appeals primarily to growth-oriented investors interested in exposure to innovative medical technology companies rather than those prioritizing current yield.

CLPT key facts

Asset type
Stock
Asset class
Equity
Inception date
05/21/2012
Last close
$15.34
Market cap
$454,341,888
Average volume
299300.0
Payment date
07/27/2016
Beta
1.239
Payout ratio
0.0
Forward P/E
12.1065
EPS
$-1.00